Cargando…
Hepatitis and Lupus-Like Syndrome during Infliximab Therapy for Psoriasis
Biologics are very useful medications that changed the lives of many patients in the last decade. However, we still do not know about the long-term side effects of these drugs. Infliximab is an anti-TNF chimeric antibody widely used and approved for the treatment of many diseases. Lupus-like syndrom...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3764949/ https://www.ncbi.nlm.nih.gov/pubmed/24019774 http://dx.doi.org/10.1159/000354593 |
_version_ | 1782283210188652544 |
---|---|
author | Riad, Hassan Shaikha, Samya Abu Ansari, Hamda Al Naama, Khalifa Al Sada, Hussein Al Mansoori, Mariam Al |
author_facet | Riad, Hassan Shaikha, Samya Abu Ansari, Hamda Al Naama, Khalifa Al Sada, Hussein Al Mansoori, Mariam Al |
author_sort | Riad, Hassan |
collection | PubMed |
description | Biologics are very useful medications that changed the lives of many patients in the last decade. However, we still do not know about the long-term side effects of these drugs. Infliximab is an anti-TNF chimeric antibody widely used and approved for the treatment of many diseases. Lupus-like syndrome and hepatitis are among the uncommon side effects of infliximab. Most of the written literature was published for cases of rheumatology and gastroenterology. We report here a case of both hepatitis and lupus-like syndrome that occurred sequentially in the same patient and compare our finding with two case reports of the same side effects, drug and disease. |
format | Online Article Text |
id | pubmed-3764949 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | S. Karger AG |
record_format | MEDLINE/PubMed |
spelling | pubmed-37649492013-09-09 Hepatitis and Lupus-Like Syndrome during Infliximab Therapy for Psoriasis Riad, Hassan Shaikha, Samya Abu Ansari, Hamda Al Naama, Khalifa Al Sada, Hussein Al Mansoori, Mariam Al Case Rep Dermatol Published online: August, 2013 Biologics are very useful medications that changed the lives of many patients in the last decade. However, we still do not know about the long-term side effects of these drugs. Infliximab is an anti-TNF chimeric antibody widely used and approved for the treatment of many diseases. Lupus-like syndrome and hepatitis are among the uncommon side effects of infliximab. Most of the written literature was published for cases of rheumatology and gastroenterology. We report here a case of both hepatitis and lupus-like syndrome that occurred sequentially in the same patient and compare our finding with two case reports of the same side effects, drug and disease. S. Karger AG 2013-08-14 /pmc/articles/PMC3764949/ /pubmed/24019774 http://dx.doi.org/10.1159/000354593 Text en Copyright © 2013 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Users may download, print and share this work on the Internet for noncommercial purposes only, provided the original work is properly cited, and a link to the original work on http://www.karger.com and the terms of this license are included in any shared versions. |
spellingShingle | Published online: August, 2013 Riad, Hassan Shaikha, Samya Abu Ansari, Hamda Al Naama, Khalifa Al Sada, Hussein Al Mansoori, Mariam Al Hepatitis and Lupus-Like Syndrome during Infliximab Therapy for Psoriasis |
title | Hepatitis and Lupus-Like Syndrome during Infliximab Therapy for Psoriasis |
title_full | Hepatitis and Lupus-Like Syndrome during Infliximab Therapy for Psoriasis |
title_fullStr | Hepatitis and Lupus-Like Syndrome during Infliximab Therapy for Psoriasis |
title_full_unstemmed | Hepatitis and Lupus-Like Syndrome during Infliximab Therapy for Psoriasis |
title_short | Hepatitis and Lupus-Like Syndrome during Infliximab Therapy for Psoriasis |
title_sort | hepatitis and lupus-like syndrome during infliximab therapy for psoriasis |
topic | Published online: August, 2013 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3764949/ https://www.ncbi.nlm.nih.gov/pubmed/24019774 http://dx.doi.org/10.1159/000354593 |
work_keys_str_mv | AT riadhassan hepatitisandlupuslikesyndromeduringinfliximabtherapyforpsoriasis AT shaikhasamyaabu hepatitisandlupuslikesyndromeduringinfliximabtherapyforpsoriasis AT ansarihamdaal hepatitisandlupuslikesyndromeduringinfliximabtherapyforpsoriasis AT naamakhalifaal hepatitisandlupuslikesyndromeduringinfliximabtherapyforpsoriasis AT sadahusseinal hepatitisandlupuslikesyndromeduringinfliximabtherapyforpsoriasis AT mansoorimariamal hepatitisandlupuslikesyndromeduringinfliximabtherapyforpsoriasis |